Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2002-04-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1006/BBRC.2002.6761PMID 11944917
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of the C-terminal extension in the interaction of S100A1 with GFAP, tubulin, the S100A1- and S100B-inhibitory peptide, TRTK-12, and a peptide derived from p53, and the S100A1 inhibitory effect on GFAP polymerization.

  1999cited by this paper
• Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family.

  1999cited by this paper
• Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type.

  1999cited by this paper
• S100A1 utilizes different mechanisms for interacting with calcium-dependent and calcium-independent target proteins.

  1998cited by this paper
• Hydrophobic residues in the C-terminal region of S100A1 are essential for target protein binding but not for dimerization.

  1998cited by this paper
• Calcium regulation of Ndr protein kinase mediated by S100 calcium‐binding proteins

  1998cited by this paper
• Two distinct anti-allergic drugs, amlexanox and cromolyn, bind to the same kinds of calcium binding proteins, except calmodulin, in bovine lung extract.

  1997cited by this paper
• Interaction of the recombinant S100A1 protein with twitchin kinase, and comparison with other Ca2+-binding proteins.

  1997cited by this paper
• The role of cysteine residues in S100B dimerization and regulation of target protein activity.

  1997cited by this paper
• Ca2+ /S100 regulation of giant protein kinases

  1996cited by this paper
• Characterization of S-100b Binding Epitopes. IDENTIFICATION OF A NOVEL TARGET, THE ACTIN CAPPING PROTEIN, CapZ (*)

  1995cited by this paper
• Isolation and characterization of a calcium-binding protein derived from mRNA termed p9Ka, pEL-98, 18A2, or 42A by the newly synthesized vasorelaxant W-66 affinity chromatography.

  1992cited by this paper
• Internal protein sequence analysis: enzymatic digestion for less than 10 micrograms of protein bound to polyvinylidene difluoride or nitrocellulose membranes.

  1992cited by this paper
• A calcium-binding protein from rabbit lung cytosol identified as the product of growth-regulated gene (2A9) and its binding proteins.

  1991cited by this paper
• A calcium-binding protein from rabbit lung cytosol identified as the product of growth-regulated gene (2A9) and its binding proteins.

  1991cited by this paper
• Purification, characterization, and partial sequence analysis of a newly identified EF-hand type 13-kDa Ca(2+)-binding protein from smooth muscle and non-muscle tissues.

  1991cited by this paper
• Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

  1987cited by this paper
• Reversible staining and peptide mapping of proteins transferred to nitrocellulose after separation by sodium dodecylsulfate-polyacrylamide gel electrophoresis.

  1986cited by this paper

• Benzopyrone, a privileged scaffold in drug discovery: An overview of FDA‐approved drugs and clinical candidates

  2024cites this paper
• 2,2-Disubstituted 5- and 8-azachroman-4-ones: the effect on cancer growth in contrast to chromanone analogs

  2023cites this paper
• Degranulation of Murine Resident Cochlear Mast Cells: A Possible Factor Contributing to Cisplatin-Induced Ototoxicity and Neurotoxicity

  2023cites this paper
• S100 Proteins in Fatty Liver Disease and Hepatocellular Carcinoma

  2022influential citation
• S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases

  2022cites this paper
• The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases

  2021cites this paper
• Epigenetic programming underpins B‐cell dysfunction in peanut and multi‐food allergy

  2021cites this paper
• Piperidine-Mediated [3 + 3] Cyclization of 2-Amino-4H-chromen-4-ones and 2-Benzylidenemalononitriles: To Access 2-Aminochromeno[2,3-b]pyridine Derivatives.

  2021cites this paper
• Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma

  2021cites this paper
• Strategy for the synthesis of 2,2-disubstituted 8-azachromanones via Horner–Wadsworth–Emmons olefination

  2020cites this paper
• Could calgranulins and advanced glycated end products potentiate acromegaly pathophysiology?

  2019cites this paper
• Reviewing the Crystal Structure of S100Z and Other Members of the S100 Family: Implications in Calcium-Regulated Quaternary Structure.

  2019cites this paper
• S100 proteins as therapeutic targets

  2018cites this paper
• Rapid Identification and Validation of Novel Rheumatoid Arthritis Drug Treatments using an Integrative Bioinformatics Platform

  2018cites this paper
• INTERACTION BETWEEN S1OO AND THE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS

  2017cites this paper
• Oxidative Stress Impairs the Stimulatory Effect of S100 Proteins on Protein Phosphatase 5 Activity.

  2016cites this paper
• Mast cells regulate myofilament calcium sensitization and heart function after myocardial infarction

  2016cites this paper
• The Hidden Side of Disodium Cromolyn: from Mast Cell Stabilizer to an Angiogenic Factor and Antitumor Agent

  2016cites this paper
• Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling.

  2015cites this paper
• S100 proteins in cancer

  2015cites this paper
• S100A proteins as molecular targets in the ocular surface inflammatory diseases.

  2014cites this paper
• Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN‑45 gastric carcinoma cells.

  2014cites this paper
• S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer

  2014cites this paper
• Solution structure and dynamics of human S100A14

  2013cites this paper
• Suramin is a Novel Activator of PP5 and Biphasically Modulates S100-Activated PP5 Activity

  2013cites this paper
• Evidence questioning cromolyn’s effectiveness and selectivity as a ‘mast cell stabilizer’ in mice

  2012cites this paper
• Post-translational S-Nitrosylation Is an Endogenous Factor Fine Tuning the Properties of Human S100A1 Protein*

  2012cites this paper
• In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer.

  2012cites this paper
• CF2-containing acetylenephosphonates in heterocyclization reactions: the first synthesis of 2-difluoromethyl azaxanth-3-ylphosphonates.

  2011cites this paper
• Moving Aggressively: S100A4 and Tumor Invasion

  2011cites this paper
• Identification d’inhibiteurs du nonsense-mediated mRNA decay (NMD) et utilisation comme approche thérapeutique dans certaines maladies génétiques

  2011cites this paper
• Regulation of nuclear localization signal-importin α interaction by Ca[2+]/S100A6

  2011cites this paper
• S100P: a novel therapeutic target for cancer

  2011cites this paper
• Regulation of nuclear localization signal‐importin α interaction by Ca2+/S100A6

  2010cites this paper
• The effect of asthma therapeutics on signalling and transcriptional regulation of airway smooth muscle function.

  2009cites this paper
• Synergistic Ca2+ and Cu2+ requirements of the FGF1-S100A13 interaction measured by quartz crystal microbalance: an initial step in amlexanox-reversible non-classical release of FGF1.

  2008cites this paper
• Interactions of S100A2 and S100A6 with the Tetratricopeptide Repeat Proteins, Hsp90/Hsp70-organizing Protein and Kinesin Light Chain*

  2008cites this paper
• Conformation and conformational exchange of Olopatadine hydrochloride

  2008cites this paper
• Structure of calcium-bound human S100A13 at pH 7.5 at 1.8 A resolution.

  2008cites this paper
• Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.

  2006cites this paper
• Olopatadine Suppresses the Migration of THP-1 Monocytes Induced by S100A12 Protein

  2006cites this paper
• Properties of Olopatadine Hydrochloride, a New Antiallergic/Antihistamine Drug

  2004cites this paper
• Identification of intracellular target proteins of the calcium-signaling protein S100A12.

  2004cites this paper
• Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.

  2004cites this paper
• S100A1 Is a Novel Molecular Chaperone and a Member of the Hsp70/Hsp90 Multichaperone Complex*

  2004cites this paper
• Terfenadine antagonism against interleukin-4-modulated gene expression of T cell cytokines.

  2003cites this paper
• Molecular mechanisms of S100‐target protein interactions

  2003cites this paper
• Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells.

  2003cites this paper
• Oxidized S 100 A 4 inhibits the activation of protein phosphatase 5 through S 100 A 1 in MKN ‐ 45 gastric carcinoma cells

  year unknowncites this paper